Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Therapy for Mental Health Providers in Training
NCT07102576Phase 1Recruiting
- Start
- Feb 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of midomafetamine in burnout syndrome. Primary endpoint: Mental Health Continuum-Short Form. Started Feb 2026; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
burnout syndrome
Beyond the preview
Go deeper on NCT07102576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07102576.